Fallopian Tube

Treatment Stage Short Name Protocol Title ClinicalTrials.Gov Link Penn Research Coordinator Am I Eligible? 
Recurrent  GOG3045 MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator’s Choice of Chemotherapy in Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression NCT04209855 Katie Elkins Eligibility Criteria 
Recurrent CAPRI CAPRI: Combination ATR and PARP Inhibitor (CAPRI) Trial with AZD6738 and Olaparib in Recurrent Ovarian Cancer NCT03462342 Cristian Tolento Eligibility Criteria 
Recurrent GOG3059 A Phase 3, Randomized, Double-Blind, Adaptive,
Placebo/Paclitaxel-Controlled Study of AVB-S6-500 in
Combination with Paclitaxel in Patients with Platinum-
Resistant Recurrent Ovarian Cancer (AXLerate-OC)
NCT04729608 Isabel Forbes Eligibility Criteria